<DOC>
	<DOCNO>NCT00082043</DOCNO>
	<brief_summary>This study explore effect dutasteride mood stress response across menstrual cycle . Dutasteride block production neurosteroids-hormones help regulate stress response system . These system may disturb woman menstrually related mood disorder ( MRMD ) . The effect drug compare woman without MRMD determine neurosteroids regulate mood stress response across menstrual cycle . Dutasteride approve Food Drug Administration treat benign prostatic hyperplasia ( excess growth prostate gland ) men . Menstruating woman 30 45 year age without MRMD may eligible study . Candidates screen medical psychiatric history , physical examination , screen symptom depression , routine blood urine test . Participants require use barrier contraception ( condoms diaphragm ) 3-month study 6-month follow-up . Participants undergo follow test procedure : - Dutasteride placebo treatment : Participants receive 1 month dutasteride 2 month placebo . Neither participant investigator know subject take active medication placebo . - Biweekly follow-up visit : Every 2 week 3-month treatment period , patient come NIH Clinical Center blood drawn complete mood symptom rating . - Monthly follow-up visit : Participants return Clinical Center month 6 month end treatment period monitor hormone level pregnancy status .</brief_summary>
	<brief_title>Dutasteride Treat Women With Menstrually Related Mood Disorders</brief_title>
	<detailed_description>Studies premenstrual syndrome ( PMS ) date demonstrate syndrome represent abnormal response normal physiological event . Specifically patient PMS experience dysphoric mood state response normal luteal phase level progesterone additionally fail demonstrate augmentation hypothalamic-pituitary-adrenal ( HPA ) axis normally see luteal phase . A parsimonious explanation dysregulation mood HPA axis function PMS mediate abnormal level response progesterone neurosteriod metabolite , allopregnanolone . Both exposure withdrawal allopregnanolone show precipitate adverse mood state animal study , presumably consequent induce conformational change GABA ( A ) receptor ( increase alpha-4 subunit ) impair GABA receptor function . This impairment GABA receptor function may also associate loss restraint HPA axis activity hence may underlie luteal phase increase HPA activity normal woman . In protocol , propose block conversion progesterone allopregnanolone woman menstrual-related mood disorder ( MRMD ; equivalent report severe form PMS call premenstrual dysphoric disorder ( PMDD ) ) normal ( control ) woman . We block progesterone metabolism ( hence exposure allopregnanolone ) newly approve 5 alpha-reductase inhibitor , dutasteride . We hypothesize follow : 1 ) Elimination exposure allopregnanolone woman MRMD eliminate dysphoric mood luteal phase ; 2 ) Elimination exposure normal control woman allopregnanolone eliminate luteal phase enhancement stimulate stress axis activity response . These hypothesis , confirm , increase precision dissect pathophysiological mechanism involve MRMD menstrual-related stress physiology . In protocol , study objective follow : Primary Objectives : 1 ) Determine whether suppression neurosteroid synthesis diminish mood symptom woman MRMD . 2 ) Determine suppression neurosteroid synthesis eliminate luteal phase-related increase stimulate HPA axis activity control woman . Secondary Objectives : 1 ) Determine whether difference response allopregnanolone account divergent effect menstrual cycle phase HPA axis activity patient MRMD control . 2 ) Determine Dex-CRH test , like grade stressor treadmill test , reveal effect menstrual cycle phase HPA axis function .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>INCLUSION CRITERIA : Healthy control woman meet criterion MRMD . The criterion MRMD , Protocol 81M126 , `` The Phenomenology Biophysiology Menstrually Regulated Mood Behavior Disorders , '' briefly follow : 1 . History within last two year least six month menstruallyrelated mood behavioral disturbance severity sufficient cause least moderate subjective distress ; 2 . Symptoms sudden onset offset , symptom severe week prior menstruation tend disappear abruptly first day menstruation ; 3 . Age 3050 year ; 4 . In good physical health ; 5 . To qualify study inclusion , woman MRMD prospectively demonstrate least two three menstrual cycle 30 % worsen mean negative mood symptom premenstrual period compare week follow menses , correct range scale employ . Healthy control symptom MRMD ( confirm prospectively ) , age 30 50 , good physical health . In addition subject normal clinical breast exam prior study entry . EXCLUSION CRITERIA : Subjects exclude study follow reason : 1 . Pregnancy intent become pregnant ; 2 . Medical illness , particular diabetes , cardiac renal disease ; 3 . Use psychotropic hormonal medication within three month prior study ; 4 . Current prescription medication use ; 5 . History current alcohol drug abuse dependence ; 6 . A history ( within past two year ) current psychiatric disorder determine administration Structured Clinical Interview DSMIV Axis I Disorders ( SCID ) ; 7 . Male gender ; 8 . Age le 30 year ; 9 . Women history carcinoma breast , woman family history following : premenopausal breast cancer bilateral breast cancer first degree relative ; multiple family member ( great three relative ) history postmenopausal breast cancer . In addition , due long half life dutasteride teratogenic effect male fetus , woman already decide discontinue childbearing willing continue barrier contraception 6 month study include protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 5, 2016</verification_date>
	<keyword>Neurosteroids</keyword>
	<keyword>5 Alpha-Reductase Inhibitor</keyword>
	<keyword>Depression</keyword>
	<keyword>Menstrual Cycle</keyword>
	<keyword>Gonadal Steroids</keyword>
	<keyword>Menstrual Cycle Related Mood Disorder</keyword>
	<keyword>MRMD</keyword>
	<keyword>Healthy Volunteer</keyword>
</DOC>